Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

H1B Visa Policy Changes Drive Pharmaceutical R&D and AI Operations to Indian Global Capability Centers post image

H1B Visa Policy Changes Drive Pharmaceutical R&D and AI Operations to Indian Global Capability Centers

White House Policy Initiatives Influence Pfizer Drug Pricing and Announce New Direct-to-Consumer Platform post image

White House Policy Initiatives Influence Pfizer Drug Pricing and Announce New Direct-to-Consumer Platform

FedEx Launches Dublin-Indianapolis Air Freight Route to Expedite Healthcare Shipments post image

FedEx Launches Dublin-Indianapolis Air Freight Route to Expedite Healthcare Shipments

US Pharma Tariffs Threaten Swiss Economy, Impacting Global Drugmakers post image

US Pharma Tariffs Threaten Swiss Economy, Impacting Global Drugmakers

Global API Market Set to Exceed $445 Billion by 2035, Driven by Biologics and Supply Chain Resilience post image

Global API Market Set to Exceed $445 Billion by 2035, Driven by Biologics and Supply Chain Resilience

Virupaksha Organics Files for ₹740 Cr IPO to Boost API Manufacturing Capacity post image

Virupaksha Organics Files for ₹740 Cr IPO to Boost API Manufacturing Capacity

Novo Nordisk Announces Global Workforce Reduction and Organizational Transformation, Impacting Irish Operations post image

Novo Nordisk Announces Global Workforce Reduction and Organizational Transformation, Impacting Irish Operations

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru post image

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives post image

GSK Appoints Luke Miels as CEO Amidst Looming US Tariffs and Strategic Growth Initiatives

API Manufacturer Virupaksha Organics Files for Rs 740-Crore IPO with SEBI post image

API Manufacturer Virupaksha Organics Files for Rs 740-Crore IPO with SEBI

India's Pharma & Biotech Exports Target $30B Amidst New Government Innovation Partnership post image

India's Pharma & Biotech Exports Target $30B Amidst New Government Innovation Partnership

Hanmi Pharmaceutical's Encequidar Deal with Gilead Sciences Boosts Shares Amid Global Market Shifts post image

Hanmi Pharmaceutical's Encequidar Deal with Gilead Sciences Boosts Shares Amid Global Market Shifts